The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT
Public ClinicalTrials.gov record NCT00002436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Lamivudine (3TC)/Dideoxycytidine (ddC) Double-Blind Multicenter Trial (With Open-Label AZT) to Evaluate the Safety and Efficacy of Low Dose 3TC Administered Concurrently With AZT Versus High Dose 3TC Administered Concurrently With AZT Versus ddC Administered Concurrently With AZT in the Treatment of HIV-1 Infected, AZT-Experienced (>= 24 Weeks) Patients With CD4 Counts of 100-300 Cells/mm3
Study identification
- NCT ID
- NCT00002436
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Glaxo Wellcome
- Industry
- Enrollment
- 325 participants
Conditions and interventions
Conditions
Interventions
- Lamivudine Drug
- Zidovudine Drug
- Zalcitabine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Combat Group | Los Angeles | California | 90028 | — |
| San Diego Community Research Group | San Diego | California | 92104 | — |
| ViRx Inc | San Francisco | California | 94103 | — |
| AIDS Research Consortium of Atlanta | Atlanta | Georgia | 30308 | — |
| Chicago Ctr for Clinical Research | Chicago | Illinois | 60607 | — |
| Louisiana Cardiovascular Research Ctr | New Orleans | Louisiana | 70119 | — |
| Boston City Hosp / FGH-1 | Boston | Massachusetts | 02118 | — |
| Nassau County Med Ctr | East Meadow | New York | 11554 | — |
| Saint Luke's - Roosevelt Hosp Ctr | New York | New York | 10019 | — |
| Nalle Clinic | Charlotte | North Carolina | 28207 | — |
| Duke Univ Med Ctr | Durham | North Carolina | 27710 | — |
| Portland Veterans Adm Med Ctr / Rsch & Education Grp | Portland | Oregon | 97210 | — |
| Milton S Hershey Med Ctr | Hershey | Pennsylvania | 17033 | — |
| Central Texas Med Foundation | Austin | Texas | 78751 | — |
| Univ of Texas Southwestern Med Ctr of Dallas | Dallas | Texas | 75235 | — |
| Nicholaos Bellos | Dallas | Texas | 75246 | — |
| Houston Clinical Research Network | Houston | Texas | 77006 | — |
| Wisconsin Community - Based Research Consortium | Milwaukee | Wisconsin | 53202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00002436 live on ClinicalTrials.gov.